Literature DB >> 16806442

Pelvic lymphadenectomy for cervical carcinoma: laparotomy extraperitoneal, transperitoneal or laparoscopic approach? A randomized study.

Pierluigi Benedetti Panici1, Francesco Plotti, Marzio Angelo Zullo, Ludovico Muzii, Natalina Manci, Innocenza Palaia, Alfonso Ruggiero, Roberto Angioli.   

Abstract

OBJECTIVE: To compare transperitoneal, extraperitoneal and laparoscopic pelvic lymphadenectomy in terms of feasibility and morbidity in patients affected by cervical cancer undergoing radical hysterectomy.
METHODS: Consecutive patients affected by stage IB-IIB cervical carcinoma scheduled for radical surgery entered the study. Patients were randomly assigned to transperitoneal (TPL), extraperitoneal (EPL) or laparoscopic pelvic lymphadenectomy (LPL). All patients underwent classical radical hysterectomy. Perioperative data were recorded. Follow up examinations were performed at the 15th, 30th and 60th day after surgery.
RESULTS: 168 patients entered the study. The mean operative times were: 63+/-7.6, 54+/-6.7 and 75+/-8.4 min (TPL vs EPL P<0.001; EPL vs LPL P<0.001; TPL vs LPL P<0.001) for TPL, EPL and LPL respectively. The feasibility of the procedures, analyzed on an intention-to-treat basis, was 96%, 93% and 95% for TPL, EPL and LPL group respectively (P=ns). The average hospitalizations were: 5.6+/-0.9, 3.2+/-0.4 and 3.1+/-0.3 days (TPL vs EPL P<0.001; TPL vs LPL P<0.001) for TPL, EPL and LPL respectively.
CONCLUSIONS: EPL and LPL are as feasible and effective as TPL and can be adequately performed with a reasonable complication rate. LPL showed a statistically significant longer operative time. However, both EPL and LPL can minimize some postoperative complications reducing length of stay.

Entities:  

Mesh:

Year:  2006        PMID: 16806442     DOI: 10.1016/j.ygyno.2006.05.025

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


  4 in total

1.  Prevention of lymphocele development in gynecologic cancers by the electrothermal bipolar vessel sealing device.

Authors:  Naotake Tsuda; Kimio Ushijima; Kouichiro Kawano; Shuji Takemoto; Shin Nishio; Gounosuke Sonoda; Toshiharu Kamura
Journal:  J Gynecol Oncol       Date:  2014-07-03       Impact factor: 4.401

2.  Incidence and risk of venous thromboembolism according to primary treatment type in women with endometrial cancer: a population-based study.

Authors:  Jin-Sung Yuk; Banghyun Lee; Kidong Kim; Myoung Hwan Kim; Yong-Soo Seo; Sung Ook Hwang; Yong Kyoon Cho; Yong Beom Kim
Journal:  BMC Cancer       Date:  2021-10-30       Impact factor: 4.430

3.  A collagen-fibrin patch (Tachosil®) for the prevention of symptomatic lymphoceles after pelvic lymphadenectomy in women with gynecologic malignancies: a randomized clinical trial.

Authors:  Christoph Grimm; Stephan Polterauer; Samir Helmy; David Cibula; Michal Zikan; Alexander Reinthaller; Clemens Tempfer
Journal:  BMC Cancer       Date:  2014-08-30       Impact factor: 4.430

4.  Risk factors and treatment of venous thromboembolism in perioperative patients with ovarian cancer in China.

Authors:  Wentong Zhang; Xiaofei Liu; Hongyan Cheng; Zhaojie Yang; Guiyu Zhang
Journal:  Medicine (Baltimore)       Date:  2018-08       Impact factor: 1.817

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.